Billy Evans, partner of Theranos founder Elizabeth Holmes, is working on a new startup, according to the New York Times, which is intended to provide “human health optimization” through blood tests through blood tests.
According to reports, the Times spoke to two investors called the startup called Haanthus, and also looked at some of Haanthus’s marketing materials.
In these materials, the company has developed a machine with which laser is analyzed for analyzing blood, saliva and urine samples for the detection of cancer and infections. It is supposedly planned to start pets’ health before expanding to humans and tries to collect more than 50 million dollars.
The pitch reflects the one for Theranos, which promised to carry out a variety of medical tests on tiny amounts of blood that come from fingers that come from fingers. In 2022, Holmes (with which Evans has two children) was sentenced to 11 years in prison because she had cheated investors, even though she recently said in an interview that she was still “providing me with affordable health solutions for everyone”.
The early Facebook investor Jim Breyer told the Times that his team was asked to invest, but declined, “for many of the same reasons why we got to Theranos twice”.